Anemia

Pre-Dialysis Anemia Ups Mortality After Dialysis Start

Pre-Dialysis Anemia Ups Mortality After Dialysis Start

By

Patients with vs without anemia prior to starting hemodialysis (HD) were more likely to die despite achieving target hemoglobin levels at month 4 after HD initiation.

Reducing PTH Might Improve Anemia in Hemodialysis

Reducing PTH Might Improve Anemia in Hemodialysis

By

Anemia control may be one more reason to treat elevated parathyroid hormone levels.

FGF23 Predicts Development of CKD Anemia

FGF23 Predicts Development of CKD Anemia

By

Anemia is 66% and 84% more likely to develop among patients in the 3rd and 4th quartiles of serum fibroblast growth factor 23 level vs those in the 1st quartile.

FDA Approves 'Biosimilar' Drug to Treat Certain Types of Anemia

FDA Approves 'Biosimilar' Drug to Treat Certain Types of Anemia

Retacrit is biosimilar to the drugs Epogen and Procrit.

Change in Red Blood Cell Distribution Width Tied With Mortality in HD

Change in Red Blood Cell Distribution Width Tied With Mortality in HD

By

In a study, increases in red blood cell distribution width during the first year of dialysis was associated with greater risks for death.

Vadadustat Maintains Hemoglobin Levels in Hemodialysis Patients

Vadadustat Maintains Hemoglobin Levels in Hemodialysis Patients

By

Patients' mean hemoglobin levels stayed relatively stable after converting from an erythropoiesis-stimulating agent to the investigational drug.

No Reduction in Platelets Found With IV Iron Use in CKD

No Reduction in Platelets Found With IV Iron Use in CKD

By

New study shows that IV iron repletion with sodium ferric gluconate complex increased platelet count significantly at week 3 post-infusion and non-significantly at week 4.

FDA Updates Triferic Label With New Safety Warning

FDA Updates Triferic Label With New Safety Warning

By

Clinicians should advise women who could become pregnant to use effective contraception before and after taking the anemia drug.

Anticoagulation Therapy May Prevent CV Events, Worsen Anemia in CKD

Anticoagulation Therapy May Prevent CV Events, Worsen Anemia in CKD

By

In a study, use of anticoagulants was associated with 85% fewer atherosclerotic events.

Calcitriol Found Not to Improve Hepcidin Levels in CKD

Calcitriol Found Not to Improve Hepcidin Levels in CKD

By

In a trial, oral calcitriol of 0.5 mcg daily did not reduce hepcidin levels in patients with stage 3 to 4 CKD.

Higher-Dose IV Iron Appears Safe in Dialysis

Higher-Dose IV Iron Appears Safe in Dialysis

By

Dialysis patients receiving more or less than 200 mg per month of IV iron had similar risks of death, infection, cardiovascular disease, and hospitalization, meta-analysis shows.

FDA Broadens Feraheme Use for Iron Deficiency Anemia

FDA Broadens Feraheme Use for Iron Deficiency Anemia

The Food and Drug Administration broadened the existing labeling for Feraheme (ferumoxytol injection) beyond the current chronic kidney disease indication.

Most CKD Patients With Anemia Show Limited Response to Oral Iron

Most CKD Patients With Anemia Show Limited Response to Oral Iron

By

In a 52-week trial, more than half of nondialysis-dependent chronic kidney disease patients with anemia treated with oral iron had no rise in their hemoglobin levels.

Anemia in Dialysis Patients Linked With Hemorrhagic Stroke

Anemia in Dialysis Patients Linked With Hemorrhagic Stroke

By

Patients with hemoglobin values of 9.7 g/dL or below had more than double the risk for hemorrhagic stroke compared with patients with hemoglobin values of 11.2 g/dL or above.

CERA Effective for Pediatric Hemodialysis Patients With Anemia

CERA Effective for Pediatric Hemodialysis Patients With Anemia

By

The safety profile of CERA is similar for children as for adults.

Lower IV Iron Dosing in Anemic Dialysis Patients May Be More Effective

Lower IV Iron Dosing in Anemic Dialysis Patients May Be More Effective

By

To support ESA therapy, IV iron at doses below 300 mg/month may be most effective for the average hemodialysis patient, according to an observational study.

Ceruloplasmin a Possible Marker of CKD in Sickle Cell Anemia

Ceruloplasmin a Possible Marker of CKD in Sickle Cell Anemia

Urinary ceruloplamin has potential to be a chronic kidney disease biomarker for patients with sickle cell anemia.

Darbepoetin Alfa Safe for Pediatric CKD Patients With Anemia

Darbepoetin Alfa Safe for Pediatric CKD Patients With Anemia

By

Researchers tested once weekly and biweekly administration of darbepoetin alfa in children aged 1 to 18 years not previously treated with an erythropoiesis-stimulating agent.

Residual Renal Function Not Linked to ESA Requirements

Residual Renal Function Not Linked to ESA Requirements

By

Researchers find no significant difference in the median erythropoietin resistance index between patients with versus without residual renal function.

Case: Treating Iron Deficiency Anemia in a Heart Failure Patient

Case: Treating Iron Deficiency Anemia in a Heart Failure Patient

To shed light on the often-challenging management of this common condition, a case of a hypothetical patient was presented to a doctor who specializes in advanced heart failure and transplant cardiology.

High ESA and Iron Doses Up CVD, Death Risk in Hemodialysis Patients

High ESA and Iron Doses Up CVD, Death Risk in Hemodialysis Patients

By

High doses of iron are associated with a significantly higher risk of cardiovascular disease, regardless of the dose of erythropoiesis-stimulating agent.

Ferric Citrate Approved for Anemia in CKD Patients

Ferric Citrate Approved for Anemia in CKD Patients

By

Study results show that the phosphate binder was superior to placebo in raising hemoglobin levels in non-dialysis-dependent CKD patients with iron-deficiency anemia.

IV Iron, Erythropoietin Equally Effective for Anemia in HD Patients

IV Iron, Erythropoietin Equally Effective for Anemia in HD Patients

By

Intravenous iron and erythropoietin produced a similar hemoglobin response among hemodialysis patients with moderate anemia.

Higher Hemoglobin Levels, Better Graft Function Linked

Higher Hemoglobin Levels, Better Graft Function Linked

By

The group targeting higher hemoglobin values experienced less decline in graft function.

Predialysis Anemia Treatment May Cut Mortality After HD Initiation

Predialysis Anemia Treatment May Cut Mortality After HD Initiation

By

HD patients with untreated or ineffectively treated anemia prior to dialysis initiation were more likely to die than those who had consistently well-treated anemia.

Anemia Raises ESRD Risk in Patients With Chronic Kidney Disease

Anemia Raises ESRD Risk in Patients With Chronic Kidney Disease

By

In a study, end-stage renal disease was 31% more likely to develop in CKD patients with versus without anemia.

Anemia Linked to High FGF23 Levels in CKD Patients

Anemia Linked to High FGF23 Levels in CKD Patients

By

CKD patients in the 3rd and 4th quartiles of c-terminal serum fibroblast growth factor 23 had a 74% and 73% higher risk for anemia compared with those in the 1st quartile.

Anemia Risk Factors in Diabetic Nephropathy Patients Identified

Anemia Risk Factors in Diabetic Nephropathy Patients Identified

By

Proteinuria and renin-angiotensin-aldosterone system inhibitors are independently associated with a significant 6-fold increased odds for anemia in patients with diabetic nephropathy.

Hereditary Hemochromatosis Patients Can Be Blood Donors

Hereditary Hemochromatosis Patients Can Be Blood Donors

No data to suggest that nonvoluntary nature of donations compromises safety of blood products.

Long-Acting ESAs Can Save Time, Costs

Long-Acting ESAs Can Save Time, Costs

Findings based upon time costs of preparation and administration per patient.

Sign Up for Free e-newsletters